New episode focuses on how TissueTech’s human birth tissue products are redefining regenerative medicine by helping repair and restore diseased or damaged cells
Miami, FL – January 4, 2021 – TissueTech, Inc., a pioneer in the clinical application of cryopreserved amniotic membrane and umbilical cord birth tissue allografts, announced today that its products will be featured on a new episode of Behind the Scenes, hosted by Emmy award-winning actor Laurence Fishburne. This new episode of the award-winning educational television series will highlight the evolution of TissueTech’s proprietary human birth tissue technology to successfully treat patients living with unmet clinical needs.
“TissueTech is extremely proud to partner with Behind the Scenes to increase awareness of all the work we have been doing to find new solutions for unmet patient needs in wound care, eye care, pain management and for rare diseases such as Spina Bifida,” said TissueTech co-founder, President, and Chief Executive officer Amy Tseng, MBA. “As a result of an aging population and the increased prevalence of chronic diseases, our products, and proprietary technology are playing an increasingly important role in patient care. We are excited to highlight this through our Behind the Scenes segment.”
The episode goes into details about how TissueTech is pioneering the future of regenerative medicine with its scientific discoveries, technologies, and applications. The company’s products help physicians provide hope to their patients where there had previously been none for many debilitating conditions. The segment also outlines how TissueTech is living its vision of empowering healthcare professionals to deliver optimal patient healing outcomes while setting the standards that redefine regenerative medicine.
You can see a sneak peek of the TissueTech segment of the episode at https://tissuetech.com/newsroom/images-and-videos/.
About TissueTech, Inc.
TissueTech, Inc., the parent company of Amniox Medical, Inc. and Bio-Tissue, Inc., is a scientific and market leader in the field of regenerative medicine. TissueTech manufactures a broad range of ocular, surgical, wound care, and soft tissue products that are marketed under these subsidiaries. Since the company’s inception, clinicians have performed more than 500,000 human implants of the company’s products and published more than 360 peer-reviewed studies supporting its platform technology. TissueTech is committed to an unwavering culture of integrity that places our patients’ safety and clinical outcomes above all else. Learn more at https://tissuetech.com/.
About Behind The Scenes
Behind the Scenes is an award-winning program that highlights new stories and innovative concepts through groundbreaking short-form and long-form documentary presentation. The program, anchored by a veteran production team with decades of industry experience, can effectively communicate the most critical stories to a broad and diverse audience. Learn more at: https://behindthesceneslf.com/.